Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: Preliminary results from the phase 2 CheckMate 436 trial Meeting Abstract
| Authors: | Moskowitz, A. J.; Santoro, A.; Gritti, G.; Brice, P.; Cunningham, D.; Barr, P.; Kline, J.; Kuruvilla, J.; Johnson, N. A.; Mehta-Shah, N.; Manley, T.; Sharma, M.; Francis, S.; Cohen, J.; Zinzani, P. L. |
| Abstract Title: | Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: Preliminary results from the phase 2 CheckMate 436 trial |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837605067 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-112069 |
| Notes: | Meeting Abstract: 1691 -- Source: Wos |
